Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder Neoplasms | 12 | 2019 | 164 | 3.050 |
Why?
|
| Cystectomy | 11 | 2019 | 104 | 2.130 |
Why?
|
| Prostatectomy | 11 | 2016 | 83 | 1.210 |
Why?
|
| Prostatic Neoplasms | 8 | 2016 | 282 | 0.860 |
Why?
|
| Internet | 6 | 2009 | 126 | 0.730 |
Why?
|
| Nephrectomy | 4 | 2015 | 48 | 0.700 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2019 | 56 | 0.690 |
Why?
|
| Laparoscopy | 7 | 2022 | 156 | 0.650 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2019 | 6 | 0.610 |
Why?
|
| Cell Membrane Permeability | 1 | 2019 | 44 | 0.610 |
Why?
|
| Cytosol | 1 | 2019 | 49 | 0.600 |
Why?
|
| Green Fluorescent Proteins | 1 | 2019 | 101 | 0.600 |
Why?
|
| Students, Medical | 4 | 2009 | 102 | 0.580 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2018 | 26 | 0.580 |
Why?
|
| Risk Assessment | 7 | 2018 | 622 | 0.570 |
Why?
|
| Vocational Guidance | 2 | 2008 | 3 | 0.560 |
Why?
|
| Peritoneal Cavity | 1 | 2017 | 13 | 0.550 |
Why?
|
| Aged | 21 | 2019 | 5525 | 0.550 |
Why?
|
| Veins | 1 | 2017 | 19 | 0.550 |
Why?
|
| Spectrum Analysis | 1 | 2017 | 32 | 0.540 |
Why?
|
| Arteries | 1 | 2017 | 66 | 0.530 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2017 | 77 | 0.500 |
Why?
|
| Adipose Tissue | 1 | 2017 | 185 | 0.490 |
Why?
|
| Humans | 36 | 2021 | 28581 | 0.430 |
Why?
|
| Carcinoma, Small Cell | 1 | 2013 | 15 | 0.410 |
Why?
|
| Specialization | 3 | 2008 | 19 | 0.410 |
Why?
|
| Neoadjuvant Therapy | 4 | 2014 | 74 | 0.410 |
Why?
|
| Aged, 80 and over | 9 | 2018 | 2045 | 0.390 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 595 | 0.380 |
Why?
|
| Male | 26 | 2021 | 13771 | 0.360 |
Why?
|
| Robotic Surgical Procedures | 3 | 2017 | 51 | 0.350 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 101 | 0.340 |
Why?
|
| United States | 10 | 2017 | 2201 | 0.340 |
Why?
|
| Middle Aged | 16 | 2018 | 7310 | 0.340 |
Why?
|
| Medicine | 2 | 2008 | 22 | 0.330 |
Why?
|
| Software Design | 2 | 2008 | 7 | 0.330 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2012 | 164 | 0.330 |
Why?
|
| Retrospective Studies | 11 | 2021 | 2612 | 0.320 |
Why?
|
| Urethral Neoplasms | 1 | 2009 | 3 | 0.310 |
Why?
|
| Neoplasms, Second Primary | 1 | 2009 | 21 | 0.300 |
Why?
|
| Ovariectomy | 2 | 2019 | 53 | 0.290 |
Why?
|
| Postoperative Complications | 5 | 2015 | 631 | 0.290 |
Why?
|
| Female | 14 | 2021 | 15471 | 0.280 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2007 | 4 | 0.280 |
Why?
|
| Urination Disorders | 1 | 2007 | 9 | 0.280 |
Why?
|
| Urethral Stricture | 1 | 2007 | 7 | 0.270 |
Why?
|
| Urinary Diversion | 1 | 2007 | 26 | 0.270 |
Why?
|
| Urologic Neoplasms | 2 | 2017 | 13 | 0.260 |
Why?
|
| Anatomy, Artistic | 1 | 2006 | 1 | 0.260 |
Why?
|
| Medical Illustration | 1 | 2006 | 3 | 0.260 |
Why?
|
| Histology | 1 | 2006 | 7 | 0.260 |
Why?
|
| Adult | 10 | 2021 | 7922 | 0.250 |
Why?
|
| Computer-Assisted Instruction | 1 | 2006 | 30 | 0.250 |
Why?
|
| Databases, Factual | 4 | 2017 | 265 | 0.240 |
Why?
|
| Education, Medical | 1 | 2006 | 68 | 0.240 |
Why?
|
| Prostatic Hyperplasia | 2 | 2015 | 9 | 0.240 |
Why?
|
| Urethral Diseases | 2 | 2015 | 6 | 0.240 |
Why?
|
| Penile Diseases | 2 | 2015 | 9 | 0.230 |
Why?
|
| Penis | 2 | 2015 | 16 | 0.230 |
Why?
|
| Urethra | 2 | 2015 | 33 | 0.230 |
Why?
|
| Risk Factors | 8 | 2015 | 2111 | 0.210 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 300 | 0.190 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2015 | 337 | 0.190 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 302 | 0.180 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2021 | 5 | 0.180 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2021 | 6 | 0.180 |
Why?
|
| Tomography, Optical Coherence | 1 | 2022 | 95 | 0.170 |
Why?
|
| Swine | 2 | 2022 | 238 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 5 | 2014 | 190 | 0.170 |
Why?
|
| Insurance, Health | 2 | 2017 | 51 | 0.160 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2014 | 113 | 0.150 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 31 | 0.150 |
Why?
|
| Fluorescence | 1 | 2019 | 51 | 0.150 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 113 | 0.150 |
Why?
|
| Lysosomes | 1 | 2019 | 56 | 0.150 |
Why?
|
| Prophylactic Surgical Procedures | 1 | 2018 | 7 | 0.150 |
Why?
|
| Biological Transport | 1 | 2019 | 124 | 0.150 |
Why?
|
| Endocytosis | 1 | 2019 | 96 | 0.150 |
Why?
|
| Ovary | 1 | 2019 | 71 | 0.150 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 681 | 0.150 |
Why?
|
| HeLa Cells | 1 | 2019 | 208 | 0.150 |
Why?
|
| Prognosis | 6 | 2021 | 807 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2021 | 194 | 0.140 |
Why?
|
| Gene Editing | 1 | 2018 | 24 | 0.140 |
Why?
|
| Urologists | 1 | 2017 | 5 | 0.140 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 49 | 0.140 |
Why?
|
| Physicians, Primary Care | 1 | 2017 | 9 | 0.140 |
Why?
|
| Intraoperative Period | 1 | 2017 | 21 | 0.140 |
Why?
|
| Watchful Waiting | 2 | 2015 | 18 | 0.140 |
Why?
|
| Insurance Coverage | 1 | 2017 | 31 | 0.140 |
Why?
|
| Time Factors | 3 | 2017 | 1600 | 0.130 |
Why?
|
| American Cancer Society | 1 | 2017 | 4 | 0.130 |
Why?
|
| Logistic Models | 3 | 2016 | 409 | 0.130 |
Why?
|
| Medicaid | 1 | 2017 | 55 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2017 | 93 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2017 | 210 | 0.130 |
Why?
|
| Ureter | 1 | 2015 | 8 | 0.120 |
Why?
|
| Neoplasm Staging | 5 | 2017 | 478 | 0.120 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2015 | 2 | 0.120 |
Why?
|
| Carcinoma, Ductal | 1 | 2015 | 3 | 0.120 |
Why?
|
| Registries | 2 | 2017 | 393 | 0.120 |
Why?
|
| Rhabdomyolysis | 1 | 2015 | 6 | 0.120 |
Why?
|
| Lymph Node Excision | 1 | 2015 | 101 | 0.120 |
Why?
|
| Administration, Intravesical | 1 | 2015 | 16 | 0.120 |
Why?
|
| Prostate | 1 | 2015 | 52 | 0.120 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2015 | 13 | 0.120 |
Why?
|
| BCG Vaccine | 1 | 2015 | 14 | 0.120 |
Why?
|
| Blood Loss, Surgical | 1 | 2015 | 53 | 0.110 |
Why?
|
| Conversion to Open Surgery | 1 | 2015 | 8 | 0.110 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2015 | 33 | 0.110 |
Why?
|
| Population Surveillance | 1 | 2015 | 86 | 0.110 |
Why?
|
| Survival Rate | 4 | 2021 | 431 | 0.110 |
Why?
|
| Robotics | 1 | 2015 | 43 | 0.110 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 145 | 0.110 |
Why?
|
| Tennessee | 3 | 2008 | 27 | 0.110 |
Why?
|
| Young Adult | 2 | 2018 | 2804 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 1026 | 0.110 |
Why?
|
| Perioperative Care | 1 | 2014 | 35 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2015 | 160 | 0.100 |
Why?
|
| Carcinoma | 1 | 2014 | 74 | 0.100 |
Why?
|
| Disease Progression | 1 | 2015 | 475 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 302 | 0.100 |
Why?
|
| Treatment Outcome | 4 | 2016 | 2402 | 0.090 |
Why?
|
| Animals | 3 | 2022 | 10580 | 0.080 |
Why?
|
| Hydronephrosis | 1 | 2010 | 11 | 0.080 |
Why?
|
| Adolescent | 2 | 2021 | 3165 | 0.080 |
Why?
|
| Feedback | 1 | 2009 | 33 | 0.080 |
Why?
|
| Patient Readmission | 1 | 2010 | 107 | 0.080 |
Why?
|
| Incidence | 3 | 2015 | 568 | 0.080 |
Why?
|
| Urothelium | 1 | 2009 | 35 | 0.080 |
Why?
|
| Pharmacy Administration | 1 | 2008 | 1 | 0.070 |
Why?
|
| Medical Informatics Applications | 1 | 2008 | 7 | 0.070 |
Why?
|
| Community Health Centers | 1 | 2008 | 15 | 0.070 |
Why?
|
| Schools, Medical | 1 | 2008 | 46 | 0.070 |
Why?
|
| Program Development | 1 | 2008 | 85 | 0.070 |
Why?
|
| Urinary Catheterization | 1 | 2007 | 15 | 0.070 |
Why?
|
| Anastomosis, Surgical | 1 | 2007 | 38 | 0.070 |
Why?
|
| Career Choice | 1 | 2007 | 53 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2021 | 1272 | 0.070 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2007 | 64 | 0.060 |
Why?
|
| Morbidity | 2 | 2015 | 58 | 0.060 |
Why?
|
| Neoplasm Grading | 2 | 2015 | 105 | 0.060 |
Why?
|
| Muscle, Smooth | 2 | 2014 | 41 | 0.050 |
Why?
|
| Lymphatic Metastasis | 2 | 2015 | 126 | 0.050 |
Why?
|
| Computers | 1 | 2022 | 30 | 0.050 |
Why?
|
| Needles | 1 | 2022 | 26 | 0.050 |
Why?
|
| Adrenalectomy | 1 | 2021 | 13 | 0.040 |
Why?
|
| Genetic Code | 1 | 2018 | 2 | 0.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 14 | 0.040 |
Why?
|
| RNA, Guide | 1 | 2018 | 15 | 0.040 |
Why?
|
| Lysine | 1 | 2018 | 74 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2021 | 899 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2017 | 19 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2018 | 118 | 0.030 |
Why?
|
| Infant | 1 | 2021 | 1019 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 1167 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 509 | 0.030 |
Why?
|
| Margins of Excision | 1 | 2016 | 12 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2016 | 61 | 0.030 |
Why?
|
| Rupture | 1 | 2015 | 12 | 0.030 |
Why?
|
| Learning Curve | 1 | 2015 | 13 | 0.030 |
Why?
|
| Operative Time | 1 | 2015 | 41 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2015 | 35 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 236 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 633 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2015 | 41 | 0.030 |
Why?
|
| Child | 1 | 2021 | 2271 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2015 | 157 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 207 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 137 | 0.030 |
Why?
|
| Forecasting | 1 | 2015 | 76 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2015 | 236 | 0.030 |
Why?
|
| Oklahoma | 1 | 2017 | 1038 | 0.030 |
Why?
|
| Income | 1 | 2014 | 38 | 0.030 |
Why?
|
| Length of Stay | 1 | 2015 | 240 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2015 | 234 | 0.030 |
Why?
|
| Comorbidity | 1 | 2014 | 259 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 893 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 116 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 734 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 82 | 0.020 |
Why?
|
| Boston | 1 | 2009 | 7 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 226 | 0.020 |
Why?
|
| Consumer Behavior | 1 | 2009 | 14 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2009 | 21 | 0.020 |
Why?
|
| Data Collection | 1 | 2009 | 105 | 0.020 |
Why?
|
| Mice | 1 | 2018 | 4732 | 0.020 |
Why?
|
| Medically Uninsured | 1 | 2008 | 31 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2008 | 54 | 0.020 |
Why?
|
| Software | 1 | 2009 | 126 | 0.020 |
Why?
|
| Curriculum | 1 | 2009 | 296 | 0.020 |
Why?
|
| Teaching | 1 | 2007 | 83 | 0.020 |
Why?
|